Express Scripts Holding Co (NASDAQ:ESRX) Director Mahon Thomas P. Mac sold 5,234 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of NASDAQ ESRX traded down $0.84 during trading hours on Friday, hitting $98.48. The company’s stock had a trading volume of 3,386,770 shares, compared to its average volume of 3,248,175. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.77 and a quick ratio of 0.65. The stock has a market capitalization of $56.09 billion, a PE ratio of 13.87, a PEG ratio of 1.25 and a beta of 0.89. Express Scripts Holding Co has a 12 month low of $59.17 and a 12 month high of $100.43.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.42 by $0.01. The company had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. Express Scripts’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm earned $2.51 earnings per share. As a group, equities research analysts anticipate that Express Scripts Holding Co will post 9.08 earnings per share for the current year.

Several research firms have recently commented on ESRX. Mizuho set a $101.00 price objective on Express Scripts and gave the stock a “hold” rating in a report on Monday, November 5th. William Blair downgraded Express Scripts from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 31st. Cowen reiterated a “buy” rating and issued a $88.00 price objective on shares of Express Scripts in a report on Friday, November 2nd. Barclays lifted their price objective on Express Scripts from $83.00 to $90.00 and gave the stock an “equal weight” rating in a report on Thursday, November 1st. Finally, Royal Bank of Canada set a $101.00 price objective on Express Scripts and gave the stock a “buy” rating in a report on Thursday, November 1st. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $89.07.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. grew its stake in shares of Express Scripts by 0.4% in the third quarter. BlackRock Inc. now owns 35,572,234 shares of the company’s stock worth $3,379,717,000 after purchasing an additional 148,049 shares during the last quarter. Northern Trust Corp grew its stake in shares of Express Scripts by 0.4% in the second quarter. Northern Trust Corp now owns 10,205,190 shares of the company’s stock worth $787,943,000 after purchasing an additional 40,656 shares during the last quarter. Abrams Capital Management L.P. grew its stake in shares of Express Scripts by 20.3% in the third quarter. Abrams Capital Management L.P. now owns 3,192,304 shares of the company’s stock worth $303,301,000 after purchasing an additional 539,203 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Express Scripts by 18.9% in the second quarter. American Century Companies Inc. now owns 2,492,801 shares of the company’s stock worth $192,469,000 after purchasing an additional 395,723 shares during the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in shares of Express Scripts by 25.7% in the third quarter. Canada Pension Plan Investment Board now owns 2,477,096 shares of the company’s stock worth $235,349,000 after purchasing an additional 505,896 shares during the last quarter. 84.20% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.thecerbatgem.com/2018/11/10/express-scripts-holding-co-esrx-director-mahon-thomas-p-mac-sells-5234-shares.html.

Express Scripts Company Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Recommended Story: Growth Stocks

Insider Buying and Selling by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.